A complete application in a minute
Tailored resume and cover letter, ready to send.
IQVIA in Madrid is seeking a Site Activation Manager to lead start-up activities across global trials, ensuring activation is efficient, compliant, and on schedule.
You will work with sponsors, sites and cross-functional teams to accelerate patient enrolment and deliver high-quality study startup outcomes. This role offers exposure to diverse therapeutic areas and global delivery models.
Centurion, South Africa
Belgrade, Serbia
Tartu, Estonia
Sofia, Bulgaria
Riga, Latvia
Madrid, Spain
Full time
R1574173
At IQVIA, our Site Activation Managers play a critical role in bringing new therapies to patients faster. As part of the Global Study Leadership team, you'll lead site activation activities across global clinical trials, working with sponsors, sites and cross-functional teams to drive study start-up success. It's an opportunity to make a global impact while advancing your career in clinical research leadership.
Global Study Leadership is a global, full-service team delivering clinical trials through both therapeutically aligned and customer-dedicated delivery units. You'll work across diverse therapeutic areas and partner with leading pharmaceutical and biotechnology companies, gaining exposure to a broad range of studies, countries, regulatory environments and delivery models.
With structured career development, tailored training, mentorship and opportunities to grow across Site Activation, Clinical, Project Management, and Oversight roles, you'll build expertise that accelerates your career. Supported by a collaborative culture, flexible working environment and AI-enabled technologies, you'll help drive efficient study delivery while bringing new treatments to patients worldwide.
You'll lead study start-up activities across global, regional, and country-level programs, ensuring studies are activated efficiently, compliantly, and on schedule. Working as part of an integrated cross-functional team, you'll partner with sponsors, sites, and stakeholders worldwide to accelerate patient enrolment and drive successful clinical trial delivery.